Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

U.K. Stress Test Results: Banks To Endure Brexit Disorder

Published 11/29/2017, 12:49 AM
Updated 07/09/2023, 06:31 AM

The Bank of England (BoE) 2017 stress test results are out. This is the first time since the launch of the U.K. stress test in 2014 that all the seven major banks have shown resilience toward tough economic scenarios. Also, they are expected to be able to cope with the Brexit disorder.

Of the seven banks, Barclays (LON:BARC) PLC (NYSE:BCS) and The Royal Bank of Scotland Group (LON:RBS) plc (NYSE:RBS) emerged the weakest under the severe economic stress scenario. Nonetheless, these two are not required to raise additional capital as they have made significant progress in improving their respective capital positions this year.

The other five banks — HSBC Holdings (LON:HSBA) plc (NYSE:HSBC) , Lloyds Banking Group (LON:LLOY) plc (NYSE:LYG) , Nationwide Building Society, Santander (MC:SAN) UK and Standard Chartered (LON:STAN) plc (OTC:SCBFF) — maintained their capital levels above the minimum requirements.

Under a tougher backdrop, capital levels of these seven major banks declined to 8.3% from 13.4% of risk-weighted assets.

Tougher Scenarios This Time

The hypothetical setups in the BOE’s stress test include the Chinese economy declining 1.2% (from 0.5% decline scenario in 2016), global GDP contracting 2.4% and the U.K. GDP falling 4.7%. Moreover, domestic unemployment rate of 9.5% and a rise in interest rates to 4% (a significant change from interest rate of zero in last year’s stress test) are among the other situations.

Further, the scenario assumes the U.K. residential property prices plunging 33%, commercial property prices tumbling 40% and a fall in oil price to $24 per barrel.

Additionally, this was the first time that major the U.K. banks were tested under the Biennial Exploratory Scenario (BES). The BoE’s primary reason of conducting this test was to scrutinize banks’ strategic responses to a more challenging operating backdrop.

These were focused on banks’ business models and sustainability to long-term changes in financial and macroeconomic scenarios. The hypothetical scenarios under the BES include continued low interest rates at near 0%, a decline in global trade, weak global growth, increased competition from smaller banks and persistent misconduct expenses.

The test had a seven-year horizon to assess the trends.

Backdrop for This Annual Exercise

This is the fourth year of the BoE stress test. Last year, all the banks except Royal Bank of Scotland had cleared it.

The primary aim of the test is to determine how much the banks would lose in case of a future economic downturn. The test rounds aid in determining how banks would respond to another economic crisis and a slump in the markets. Therefore, the BoE has come up with hypothetical scenarios that were considered while conducting the stress test.

Road Ahead

The U.K. is due to leave European Union in March 2019. Though the country’s banking system will likely be able withstand Brexit disorder, shuttering of talks related to post-Brexit relationship is expected to hurt the economy.

This could result in losses to the banking system that will exceed the losses predicted under the above-mentioned tough scenarios in case Brexit is accompanied by a global recession and further penalties for business misconducts. Nonetheless, until that time, banks are expected to further strengthen their capital levels and improve the U.K.’s financial stability.

With banks taking measures to strengthen their financials and confront challenges, the stress test will further help regulators to check their progress in the same and avert another crisis. Further, this will boost the lending capacity of banks, thereby bolstering their financial positions.

Among the banks mentioned above, Standard Chartered, Royal Bank of Scotland and HSBC carry a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 (Strong Buy) Rank stocks here.

Investor Alert: Breakthroughs Pending

A medical advance is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating substantial revenue, and even more wondrous products are in the pipeline.

Cures for a variety of deadly diseases are in sight, and so are big potential profits for early investors. Zacks names 5 stocks to buy now.

Click here to see them >>

Barclays PLC (BCS): Free Stock Analysis Report

Royal Bank Scotland PLC (The) (RBS): Free Stock Analysis Report

Lloyds Banking Group PLC (LYG): Free Stock Analysis Report

Standard Chartered PLC (SCBFF): Free Stock Analysis Report

HSBC Holdings PLC (HSBC): Free Stock Analysis Report

Original post

Zacks Investment Research

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.